A Study of LDE255 in Combination With Azacitidine for High Risk Myelodysplastic Syndrome Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Pierre FENAUX, MD, PHD
Saint-Louis Hospital, Paris, France
Study Director - Thomas PREBET, MD
Paoli Calmettes institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chu D'Amiens
Amiens, France
- Chu D'Angers
Angers, France
- Ch Henri Duffaut
Avignon, France
- Ch de la Côte Basque
Bayonne, France
- Hôpital Avicenne
Bobigny, France
- Hôpital Henri Mondor
Créteil, France
- Chu de Grenoble
Grenoble, France
- Ch Le Mans
Le Mans, France
- Ipc-Unité D'Hématologie 3
Marseille, France
- Centre Hospitalier de Meaux
Meaux, France
- Chu de Montpellier
Montpellier, France
- Hôpital Hôtel Dieu
Nantes, France
- Centre Antoine Lacassagne
Nice, France
- Hôpital Archet 1
Nice, France
- Chu de Nîmes
Nîmes, France
- Hôpital Cochin
Paris, France
- Hôpital Saint Louis - Service Hématologie Sénior
Paris, France
- Hôpital Saint-Louis - Service D'Hématologie Aja
Paris, France
- Chu de Haut-Lévèque
Pessac, France
- Ch Lyon Sud
Pierre-Bénite, France
- Ch Annecy Genevois
Pringy, France
- Hôpital Henri Becquerel
Rouen, France
- Iuc Oncopole - Médecine Interne
Toulouse, France
- Chu Nancy-Brabois
Vandœuvre-lès-Nancy, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Feb 2015
- Primary completion
- 31 Jan 2018
- Completion
- 1 Aug 2018
- Last update posted
- 6 Dec 2018
- Registered enrollment
- 23
- Registry id
- NCT02323139
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.